LEP and endometrial cancer: It is noteworthy that we find that leptin is associated with increased risk of endometrial cancer in diabetic patients only (ORQ4 vs. Q1 = 3.787, 95% CI 0.903–15.876, p = 0.069), suggesting a role for leptin in elevating the risk of endometrial cancer in diabetic individuals.